STAGEMARK
StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.
STAGEMARK
Industry:
Biotechnology Software
Founded:
2004-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.stagemark.de
Total Employee:
11+
Status:
Active
Contact:
+49 33 22 - 23 45 98
Total Funding:
2.45 M USD
Technology used in webpage:
IPv6 Google Maps Strato Strato DNS
Current Employees Featured
Founder
Investors List
BioAdvance
BioAdvance investment in Series B - StageMark
Science Center
Science Center investment in Series B - StageMark
Meyer Ventures
Meyer Ventures investment in Series B - StageMark
Quaker BioVentures
Quaker BioVentures investment in Series B - StageMark
Innovation Works
Innovation Works investment in Series B - StageMark
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Series B - StageMark
BlueTree Allied Angels
BlueTree Allied Angels investment in Series B - StageMark
Innovation Works
Innovation Works investment in Venture Round - StageMark
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Venture Round - StageMark
Official Site Inspections
http://www.stagemark.de
- Host name: w84.rzone.de
- IP address: 81.169.145.84
- Location: Berlin Germany
- Latitude: 52.5174
- Longitude: 13.3985
- Timezone: Europe/Berlin
- Postal: 12529
